Invaluable Guidance: FDA’s Dean of Drug Reviews on “Enrichment Strategies”

FDA’s draft guidance on “Enrichment Strategies for Clinical Trials” fulfills an overdue goal from PDUFA IV. It also captures decades of wisdom from the agency’s senior drug review manager.